315 results about "Cyclic Hydrocarbons" patented technology

A composition comprising a polymerizable compound of the formula (1) and a rod-shaped polymerizable liquid crystal compound: P2-E2-X2-B2-A2-(G2)t-Y-(G1)s-A1-B1-X1-E1-P1   (1) (in the formula (1), Y represents a di-valent group, s and t represent each independently an integer of 0 or 1, G1 and G2 when s and t are 1 represent each independently —CR1R2—, R1 and R2 represent each independently an alkyl group having 1 to 4 carbon atoms, halogen atom or hydrogen atom, A1 and A2 represent each independently a di-valent cyclic hydrocarbon group, di-valent heterocyclic group, methylenephenylene group, oxyphenylene group or thiophenylene group, B1 and B2 represent each independently a di-valent group, X1 and X2 represent each independently a di-valent group, E1 and E2 represent each independently an alkylene group having 2 to 25 carbon atoms, and P1 and P2 represent a hydrogen atom or polymerizable group, at least one of P1 and P2 being a polymerizable group.).

Provided are mixtures of 1) compounds of the formula:wherein R1 is a saturated or unsaturated cyclic hydrocarbon optionally substituted with an alkyl and / or an OXO-ester, and R2 is a C4 to C14 hydrocarbyl; and 2) one or more second plasticizers selected from the group consisting of alkyl terephthalates, alkyl phthalates, alkyl benzoate esters, di-benzoate esters, esters of cyclohexane polycarboxylic acids, and dialkyl adipates. Also provided are plasticized polymer compositions containing said mixtures.

Compositions and methods for treating mammalian diseases or conditions characterized by undesirable angiogenesis by administering an effective amount of a compound of the formulae: wherein Ra is selected from —OCH3, —OCH2CH3 or —CCCH3; and Z is selected from >C(H)—OH, >C(H)—O-alkyl, >C(H)—O-sulfamate, where alkyl is a linear, branched and / or cyclic hydrocarbon chain comprising 1 to 10 carbons.

The present invention provides a novel 1H-indazole compound having an excellent JNK inhibitory action. More specifically, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. Wherein R<1 >is a C6-C14 aromatic cyclic hydrocarbon group etc.; R<2>, R<4 >and R<5 >each independently represent a hydrogen atom, a halogen atom, a cyano group etc.; L is a single bond, or a C1-C6 alkylene group etc.; X is a single bond, or a group represented by -CO-NH- or -NH-CO-, etc.; and Y is a C3-C8 cycloalkyl group, a C6-C14 aromatic cyclic hydrocarbon group or a 5- to 14-membered aromatic heterocyclic group etc.

The present invention relates to a phenothiazinium compound of Formula (I): wherein: A and B each independently is in which R' and R'' each independently is a linear, branched or cyclic hydrocarbon group, or R' and R'' together with the N atom to which they are attached form an optionally substituted 5-, 6- or 7-membered ring; and where X<p-> is a counteranion and P is 1, 2 or 3; except for the compounds in which A and B are both either -N(CH3)2 or -N(CH2CH3)2 for use in a treatment that requires removal, deactivation or killing of unwanted tissues or cells. The invention also relates to compositions comprising the compounds of Formula I, to selected compounds of Formula I, use of the compounds of Formula I as medicaments and as a PDT agent or a photodiagnostic agent, a conjugate or composite formed between a compound of Formula I and a polymer; and to a method for sterilising fluids in which the fluid is passed over the conjugate or composite whilst it is illuminated. The compounds are biologically active photosensitisers which are strongly photocytotoxic and have application in the areas of photodynamic therapy (PDT), as well as for the diagnosis and detection of medical conditions and related uses in photochemical internalisation, in the production of cancer vaccines, in the treatment and prevention of microbial infections and in photodisinfection or photosterilisation.

A compound represented by the general formula (1):Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4  (1)wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a groupin which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof.The compound is useful as an agent for preventing and / or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.

A process for the conversion of lignin to chemical precursors is presented. The process comprises treating the lignin to form less acidic compounds. The process includes reacting lignin with a hydrogenation catalyst under a hydrogen atmosphere to convert acidic oxygenate compounds to less acidic oxygenates or hydrocarbons. The oxygenate compounds are reacted in a dehydrogenation and deoxygenation process to remove the oxygen and to convert the cyclic hydrocarbons back to aromatic compounds.

A radiation-sensitive resin composition comprising (A) an acid-dissociable group-containing polysiloxane and (B) a photoacid generator containing trifluoromethane sulfonic acid or a compound which generates an acid of the following formula (I),wherein Rf individually represents a fluorine atom or a trifluoromethyl group, and Ra represents a hydrogen atom, a fluorine atom, a linear or branched alkyl group having 1-20 carbon atoms, or a linear or branched fluoroalkyl group having 1-20 carbon atoms, a substituted or unsubstituted monovalent cyclic hydrocarbon group having 3-20 carbon atoms, or a substituted or unsubstituted monovalent cyclic fluoro-hydrocarbon group having 3-20 carbon atoms. The radiation-sensitive resin composition of the present invention exhibits superior resolution, while maintaining high transparency to radiations and high dry etching resistance. The resin composition thus can greatly contribute to the lithography process that will become more and more minute in the future.

The benzene content in a gasoline pool is reduced by a process that hydrogenates a benzene-containing isomerization zone feedstream. The additional cyclic hydrocarbons produced by the saturation of benzene can be processed in the isomerization zone for ring opening to increase the available paraffinic feedstock or the isomerization zone can be operated to pass the cyclic hydrocarbons through to a product recovery section. The isomerization zone feedstream is treated to remove contaminants and dried before entering the hydrogenation zone.

A compound of formula [I]: X-R [I] wherein X represents the group: and R is either (i) represented by the formula [II] wherein n is 1 or 2, and the or each R7 group is independently selected from the group consisting of hydrogen and halogen atoms, cyano, nitro, mercapto, carbonyl and sulfone groups, and optionally substituted alkyl, haloalkyl, hydroxyalkyl, aryl, alkoxy, aryloxy, alkylamino, arylamino, alkylthio, arylthio, ester, siloxy, cyclic hydrocarbon and heterocyclic groups; or (ii) is selected from the group consisting of optionally substituted alkyl, hydroxyalkyl, aryl, cyclic hydrocarbon and heterocyclic groups; wherein in each case R1-R6 are each independently selected from the group consisting of hydrogen and halogen atoms, cyano, nitro, mercapto, carbonyl and sulfone groups, and optionally substituted alkyl, haloalkyl, hydroxyalkyl, aryl, alkoxy, aryloxy, alkylamino, arylamino, alkylthio, arylthio, ester, siloxy, cyclic hydrocarbon and heterocyclic groups. The compounds are useful as hole-transporting materials in electroluminescence devices.

A fluorine-containing cyclic compound is represented by the formula 1: wherein each of R1, R2 and R3 independently represents a hydrogen, alkyl group, fluorine, fluoroalkyl group or hexafluorocarbinol group,wherein at least one of the hexafluorocarbinol groups may partly or totally be protected with a protecting group, andwherein the protecting group is (a) a straight-chain, branched or cyclic hydrocarbon group having a carbon atom number of 1-25 or (b) an aromatic hydrocarbon group and optionally contains a fluorine atom, oxygen atom, nitrogen atom or carbonyl bond.

A method for synthesizing cyclic polymers using transition metal alkylidene complexes as reaction catalysts is provided, wherein the complexes contain a cyclic group. Polymerization is carried out on the catalyst, using cyclic olefin monomers that undergo ring insertion polymerization, and no linear intermediates are generated. Following completion of polymerization, the cyclic polymer detaches from the complex via an intramolecular chain transfer reaction and the catalytic complex is regenerated. The invention also provides novel transition metal alkylidene complexes useful as catalysts in the aforementioned process, as well as novel cyclic hydrocarbons.

A magnetic recording medium is disclosed, which comprises a support having thereon a magnetic layer comprising a binder and a ferromagnetic powder dispersed therein, wherein said binder comprises a polyurethane resin having at least one cyclic hydrocarbon group and at least one ether linkage, and said ferromagnetic powder is a ferromagnetic metallic powder which comprises Fe and has a mean major-axis length of from 0.05 to 0.19 .mu.m and a crystallite size of from 100 to 230 .ANG.; and further a magnetic recording medium is disclosed, comprising a support having thereon in succession an undercoat layer comprising a binder U and an inorganic powder dispersed therein and a magnetic layer comprising a binder M and a ferromagnetic powder dispersed therein, wherein at least either of the binder U or M comprises a polyurethane resin having at least one cyclic hydrocarbon group and at least one ether linkage and said ferromagnetic powder is a ferromagnetic metallic powder which comprises Fe and has a mean major-axis length of from 0.05 to 0.19 .mu.m and a crystallite size of from 100 to 230 .ANG..

For the purpose of providing a urethane(meth)acrylate excellent in emulsifiability in water and a production method thereof, and a light curable aqueous emulsion using the urethane(meth)acrylate having a low viscosity and excellent in the curability, provided is a urethane(meth)acrylate being represented by the following general formula (1) and having a weight average molecular weight of 1,000 to 10,000:A1-O—(CONH—B1-NHCOO—C1-O)n-CONH—B1-NH—COO-D1  (1)wherein in formula (1), n represents a natural number of 1 to 30, A1 represents a residue of a hydroxyl group-containing (meth)acrylate, B1 represents a residue of diisocyanate, C1 represents a residue of a diol of an acyclic hydrocarbon or a cyclic hydrocarbon, and D1 represents a residue of a polyoxyalkylene glycol monoalkyl ether.

An acid generator represented by the following formula (1) is provided:wherein X represents an alkylene group having 1 to 10 carbon atoms, —X1—O—X2—, or a heteroatom selected from the group consisting of nitrogen, sulfur and fluorine; X1 and X2 each independently represent an alkylene group having 1 to 10 carbon atoms; Y represents a cyclic hydrocarbon group having 5 to 30 carbon atoms and containing one or more aromatic rings, while one or more hydrogen atoms on the ring of the cyclic hydrocarbon group may be substituted by one or more members selected from the group consisting of —O—Y1, —CO—Y2, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a perfluoroalkyl group having 1 to 4 carbon atoms, a perfluoroalkoxy group having 1 to 4 carbon atoms, a hydroxyalkyl group having 1 to 6 carbon atoms, a halogen atom, a hydroxyl group and a cyano group; Y1 and Y2 each independently represent an alkyl group having 1 to 6 carbon atoms; n represents an integer of 0 or 5; and A+ represents an organic counterion.

The present invention provides a novel 1H-indazole compound having an excellent JNK inhibitory action. More specifically, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. Wherein R1 is a C6-C14 aromatic cyclic hydrocarbon group etc.; R2, R4 and R5 each independently represent a hydrogen atom, a halogen atom, a cyano group etc.; L is a single bond, or a C1-C6 alkylene group etc.; X is a single bond, or a group represented by —CO—NH— or —NH—CO—, etc.; and Y is a C3-C8 cycloalkyl group, a C6-C14 aromatic cyclic hydrocarbon group or a 5- to 14-membered aromatic heterocyclic group etc.

A compound represented by the following formula (I): wherein R1 represents hydrogen, aryl which may have a substituent, a saturated or unsaturated 5- to 7-membered heterocyclic group which may have a substituent, etc.; R2 represents hydrogen, aryl which may have a substituent, a saturated or unsaturated 5- to 7-membered heterocyclic group which may have a substituent, etc.; R3 represents hydrogen, etc.; Ar represents a divalent group derived from aromatic hydrocarbon, etc.; X represents a single bond, linear or branched alkylene having from 1 to 3 carbon atoms which may have a substituent, etc.; and G represents halogen, a saturated or unsaturated 5- or 6-membered cyclic hydrocarbon group which may have a substituent, a saturated or unsaturated 5- to 7-membered heterocyclic group which may have a substituent, etc., a salt thereof or a solvate thereof; and an agent for inhibiting aggregation and / or deposition of an amyloid protein or an amyloid-like protein, which comprises the compound, a salt thereof or a solvate thereof.

A compound represented by the general formula (1): Q1-Q2-T0-N(R1)-Q3-N(R2) -T1-Q4   (1) wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and / or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.

Organo-Imino molybdenum complexes are disclosed having the formula Z2N2MOS4C2N2R4 wherein Z and R are independently selected from the group consisting of linear hydrocarbon groups, branched hydrocarbon groups, cyclic hydrocarbon groups, and mixtures thereof. The compounds are useful as friction modifiers in lubricants.

This invention relates to the following general expression compound or the medicine use of its prodrug. Concretely it relates to the general expression compound or its prodrug's use in preparing TNF-alphaand / or IL-1beta inhibitor. R1 stands for hydrogen, alkyl, aryl, cyclic hydrocarbon or heterocyclic hydrocarbon. R2 stands for the following chemical formula, R' stands for hydrogen, alkyl, aryl, hetero aryl, alkoxy, halogen group, amido or hydroxy group, R'' stands for hydrogen, alkyl, cyclic hydrocarbon, aryl, hetero aryl, alkoxy, halogen group or amido.

The invention relates to a method for producing α,β-unsaturated dicarboxylic acids and the corresponding saturated dicarboxylic acids, whereby the corresponding cycloalkene and acrylic acid are reacted with a ruthenium catalyst by way of a metathesis reaction at high substrate concentrations until the reaction takes place in substance, the resulting dicarboxylic acid being precipitated.

The invention relates to the technical field of modification of copolyester, and in particular, relates to 2,5-furan dicarboxylic acid copolyester and a preparation method thereof. In allusion to theproblems that after a modification monomer is added to a conventional polyester material, either the elongation at break is too low or the young's modulus is too low, and polyester having high elongation at break and also maintaining high Young's modulus is lack, the technical scheme comprises that provided is the 2,5-furan dicarboxylic acid copolyester having the following structural formula defined in the specification, wherein R1 in the structural formula is a repeating unit of a group defined in the specification, R2 and R4 in the structural formula are hydrocarbon or heterocyclic repeating units, and R3 in the structural formula is a repeating unit containing six-membered fatty cyclic hydrocarbons or a repeating unit containing multiple saturated five-membered heterocyclic rings. Theinvention also provides the preparation method of the 2,5-furan dicarboxylic acid copolyester. The 2,5-furan dicarboxylic acid copolyester is suitable for packaging materials, textiles, engineering plastics and other fields.

The present invention provides polymerizable monomers represented by the following general formula (1) that are useful as dental materials.In the general formula (1), Ra is a divalent C6-9 aromatic hydrocarbon group or a divalent C6-9 optionally bridged cyclic hydrocarbon group, R1 and R2 are each a hydrogen atom or a C1-3 alkyl group, R3, R4, R5 and R6 are each a hydrogen atom or a hydrocarbon group, R7 and R8 are each a hydrogen atom or a methyl group, m and n are each independently 0 to 4, and Rb and Rc are each independently a C2-6 linear alkylene or C2-6 linear oxyalkylene group optionally substituted with a C1-3 alkyl group or a (meth)acryloyloxymethylene group in place of a hydrogen atom.